Furiex Reports Third Quarter 2012 Financial Results

[at noodls] – Third Quarter 2012 Highlights: Milestone revenue of $10.0 million related to Priligy® regulatory milestones. Royalty revenue of $5.6 million, an increase of $2.5 million (81.4%) from second quarter 2012. … more

View todays social media effects on FURX

View the latest stocks trending across Twitter. Click to view dashboard